Acute death caused by invasive aspergillosis after living-donor liver transplantation despite good graft function: a case report

被引:2
作者
Tomiyama, Takahiro [1 ]
Motomura, Takashi [1 ]
Iseda, Norifumi [1 ]
Morinaga, Akinari [1 ]
Shimagaki, Tomonari [1 ]
Kurihara, Takeshi [1 ]
Wang, Huanlin [1 ]
Toshima, Takeo [1 ]
Nagao, Yoshihiro [1 ]
Itoh, Shinji [1 ]
Harada, Noboru [1 ]
Yoshizumi, Tomoharu [1 ]
Mori, Masaki [1 ]
机构
[1] Kyushu Univ, Kyushu Univ Hosp, Grad Sch Med Sci, Dept Surg & Sci, 3 Chome 1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan
关键词
Invasive aspergillosis; Liver transplantation; Antifungal treatment; PULMONARY ASPERGILLOSIS; AMPHOTERICIN-B; RISK-FACTORS; VORICONAZOLE; PROPHYLAXIS; MANAGEMENT; OUTCOMES;
D O I
10.1186/s40792-021-01203-w
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Invasive aspergillosis (IA) is one of the most serious causes of death after liver transplantation (LT). IA is the second most common fungal infection, and its mortality rate exceeds 80%. Case presentation A 67-year-old man presented to our hospital because of fulminant hepatitis caused by hepatitis B virus. Candidiasis was detected in his sputum, and micafungin had already been administered. Living-donor LT was performed using a right lobe graft donated from his daughter with no intraoperative complications. Although he appeared to have good graft function, his oxygenation was inadequate, and a chest radiograph showed many invasive shadows on postoperative day 1. A computed tomography scan also showed many invasive shadows with the halo sign. A blood examination revealed positivity for Aspergillus antigen, and Aspergillus species were detected in his sputum. IA was diagnosed. The antifungal therapy was soon modified to amphotericin B combined with caspofungin. Despite good graft blood flow through the portal vein and hepatic artery and good graft function, the patient died of IA on postoperative day 3. The median time from LT to IA among reports published to date ranges from 18 to 25 days. Conclusions The present report describes the first case of very early onset of IA after LT.
引用
收藏
页数:6
相关论文
共 23 条
  • [1] Invasive pulmonary aspergillosis after liver transplantation: lessons from successfully treated cases and review of the literature
    Abe, Kodai
    Shinoda, Masahiro
    Uno, Shunsuke
    Obara, Hideaki
    Kitago, Minoru
    Abe, Yuta
    Hishida, Tomoyuki
    Yagi, Hiroshi
    Hasegawa, Yasushi
    Kitagawa, Yuko
    [J]. SURGERY TODAY, 2021, 51 (08) : 1361 - 1370
  • [2] Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients
    Balogh, Julius
    Burroughs, Sherilyn Gordon
    Boktour, Maha
    Patel, Samir
    Saharia, Ashish
    Ochoa, Robert A.
    McFadden, Robert
    Victor, David W.
    Ankoma-Sey, Victor
    Galati, Joseph
    Monsour, Howard P., Jr.
    Fainstein, Victor
    Li, Xian C.
    Grimes, Kevin A.
    Gaber, A. Osama
    Aloia, Thomas
    Ghobrial, R. Mark
    [J]. LIVER TRANSPLANTATION, 2016, 22 (02) : 163 - 170
  • [3] Invasive Aspergillosis in Liver Transplant Recipients: Epidemiology, Clinical Characteristics, Treatment, and Outcomes in 116 Cases
    Barchiesi, Francesco
    Mazzocato, Susanna
    Mazzanti, Sara
    Gesuita, Rosaria
    Skrami, Edlira
    Fiorentini, Alessandro
    Singh, Nina
    [J]. LIVER TRANSPLANTATION, 2015, 21 (02) : 204 - 212
  • [4] Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
    Donnelly, J. Peter
    Chen, Sharon C.
    Kauffman, Carol A.
    Steinbach, William J.
    Baddley, John W.
    Verweij, Paul E.
    Clancy, Cornelius J.
    Wingard, John R.
    Lockhart, Shawn R.
    Groll, Andreas H.
    Sorrell, Tania C.
    Bassetti, Matteo
    Akan, Hamdi
    Alexander, Barbara D.
    Andes, David
    Azoulay, Elie
    Bialek, Ralf
    Bradsher, Robert W., Jr.
    Bretagne, Stephane
    Calandra, Thierry
    Caliendo, Angela M.
    Castagnola, Elio
    Cruciani, Mario
    Cuenca-Estrella, Manuel
    Decker, Catherine F.
    Desai, Sujal R.
    Fisher, Brian
    Harrison, Thomas
    Heussel, Claus Peter
    Jensen, Henrik E.
    Kibbler, Christopher C.
    Kontoyiannis, Dimitrios P.
    Kullberg, Bart-Jan
    Lagrou, Katrien
    Lamoth, Frederic
    Lehrnbecher, Thomas
    Loeffler, Jurgen
    Lortholary, Olivier
    Maertens, Johan
    Marchetti, Oscar
    Marr, Kieren A.
    Masur, Henry
    Meis, Jacques F.
    Morrisey, C. Orla
    Nucci, Marcio
    Ostrosky-Zeichner, Luis
    Pagano, Livio
    Patterson, Thomas F.
    Perfect, John R.
    Racil, Zdenek
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (06) : 1367 - 1376
  • [5] Risk factors for invasive aspergillosis in liver transplant recipients
    Fortún, J
    Martín-Dávila, P
    Moreno, S
    de Vicente, E
    Nuño, J
    Candelas, A
    Bárcena, R
    García, M
    [J]. LIVER TRANSPLANTATION, 2002, 8 (11) : 1065 - 1070
  • [6] Antifungal prophylaxis in liver transplant recipients: one size does not fit all
    Giannella, M.
    Bartoletti, M.
    Morelli, M.
    Cristini, F.
    Tedeschi, S.
    Campoli, C.
    Tumietto, F.
    Bertuzzo, V.
    Ercolani, G.
    Faenza, S.
    Pinna, A. D.
    Lewis, R. E.
    Viale, P.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2016, 18 (04) : 538 - 544
  • [7] Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign
    Greene, Reginald E.
    Schlamm, Haran T.
    Oestmann, Joerg -W.
    Stark, Paul
    Durand, Christine
    Lortholary, Olivier
    Wingard, John R.
    Herbrecht, Raoul
    Ribaud, Patricia
    Patterson, Thomas F.
    Troke, Peter F.
    Denning, David W.
    Bennett, John E.
    de Pauw, Ben E.
    Rubin, Robert H.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (03) : 373 - 379
  • [8] Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
    Herbrecht, R
    Denning, DW
    Patterson, TF
    Bennett, JE
    Greene, RE
    Oestmann, JW
    Kern, WV
    Marr, KA
    Ribaud, P
    Lortholary, O
    Sylvester, R
    Rubin, RH
    Wingard, JR
    Stark, P
    Durand, C
    Caillot, D
    Thiel, E
    Chandrasekar, PH
    Hodges, MR
    Schlamm, HT
    Troke, PF
    de Pauw, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) : 408 - 415
  • [10] Effect of isavuconazole on tacrolimus and sirolimus serum concentrations in allogeneic hematopoietic stem cell transplant patients: A drug-drug interaction study
    Kieu, Van
    Jhangiani, Kristi
    Dadwal, Sanjeet
    Nakamura, Ryotaro
    Pon, Doreen
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (01)